Quarterly report pursuant to Section 13 or 15(d)

Statements of Stockholders??? (Deficit) Equity (Unaudited)

v3.22.2.2
Statements of Stockholders’ (Deficit) Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 9 $ 3,242 $ (5,922) $ (2,671)
Balance (in Shares) at Dec. 31, 2020 8,514,070      
Net loss (964) (964)
Issuance of common stock for exercise of options 31 31
Issuance of common stock for exercise of options (in Shares)   233,819      
Stock-based compensation expense 202 202
Balance at Mar. 31, 2021 $ 9 3,475 (6,886) (3,402)
Balance (in Shares) at Mar. 31, 2021 8,747,889      
Balance at Dec. 31, 2020 $ 9 3,242 (5,922) (2,671)
Balance (in Shares) at Dec. 31, 2020 8,514,070      
Net loss         (7,265)
Balance at Sep. 30, 2021 $ 15 32,169 (13,187) 18,997
Balance (in Shares) at Sep. 30, 2021 14,972,552      
Balance at Mar. 31, 2021 $ 9 3,475 (6,886) (3,402)
Balance (in Shares) at Mar. 31, 2021 8,747,889      
Net loss (1,100) (1,100)
Issuance of common stock for exercise of options 6 6
Issuance of common stock for exercise of options (in Shares)   23,401      
Stock-based compensation expense 294 294
Balance at Jun. 30, 2021 $ 9 3,775 (7,986) (4,202)
Balance (in Shares) at Jun. 30, 2021 8,771,290      
Net loss (5,201) (5,201)
Issuance of common stock for cash, net of $2.7 million offering costs $ 5 22,266 22,271
Issuance of common stock for cash, net of $2.7 million offering costs (in Shares)   5,000,000      
Conversion of convertible notes into common stock $ 1 3,684 3,685
Conversion of convertible notes into common stock (in Shares)   736,773      
Issuance of common stock for anti-dilution clause 2,191 2,191
Issuance of common stock for anti-dilution clause (in Shares)   438,374      
Issuance of common stock for exercise of options 14 14
Issuance of common stock for exercise of options (in Shares)   26,115      
Stock-based compensation expense 239 239
Balance at Sep. 30, 2021 $ 15 32,169 (13,187) 18,997
Balance (in Shares) at Sep. 30, 2021 14,972,552      
Balance at Dec. 31, 2021 $ 15 32,408 (15,939) 16,484
Balance (in Shares) at Dec. 31, 2021 14,996,534      
Net loss (3,537) (3,537)
Issuance of common stock for exercise of options 7 7
Issuance of common stock for exercise of options (in Shares)   23,983      
Stock-based compensation expense 290 290
Balance at Mar. 31, 2022 $ 15 32,705 (19,476) 13,244
Balance (in Shares) at Mar. 31, 2022 15,020,517      
Balance at Dec. 31, 2021 $ 15 32,408 (15,939) 16,484
Balance (in Shares) at Dec. 31, 2021 14,996,534      
Net loss         (12,730)
Balance at Sep. 30, 2022 $ 15 33,280 (28,669) 4,626
Balance (in Shares) at Sep. 30, 2022 15,087,943      
Balance at Mar. 31, 2022 $ 15 32,705 (19,476) 13,244
Balance (in Shares) at Mar. 31, 2022 15,020,517      
Net loss (3,636) (3,636)
Issuance of common stock for exercise of options 8 8
Issuance of common stock for exercise of options (in Shares)   23,981      
Stock-based compensation expense 294 294
Balance at Jun. 30, 2022 $ 15 33,007 (23,112) 9,910
Balance (in Shares) at Jun. 30, 2022 15,044,498      
Net loss (5,557) (5,557)
Issuance of common stock for vested restricted stock units
Issuance of common stock for vested restricted stock units (in Shares)   26,738      
Issuance of common stock for exercise of options 7 7
Issuance of common stock for exercise of options (in Shares)   16,707      
Stock-based compensation expense 266 266
Balance at Sep. 30, 2022 $ 15 $ 33,280 $ (28,669) $ 4,626
Balance (in Shares) at Sep. 30, 2022 15,087,943